Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial-Reference-Cited by-同舟云学术

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Published:2004-08 Issue:9435 Volume:364 Page:685-696
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Colhoun Helen M,Betteridge D John,Durrington Paul N,Hitman Graham A,W Neil H Andrew,Livingstone Shona J,Thomason Margaret J,Mackness Michael I,Charlton-Menys Valentine,Fuller John H

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial;Stamler;Diabetes Care,1993

2. Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project;Ho;Stroke,2003

3. The incidence and aetiology of stroke in the Caerphilly and Speedwell Collaborative Studies II: risk factors for ischaemic stroke;McCarron;Public Health,2001

4. The impact of diabetes on survival among patients with first myocardial infarction;Chun;Diabetes Care,1997

5. Factors determining case fatality in myocardial infarction “who dies in a heart attack”?;Wannamethee;Br Heart J,1995

Cited by 3220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early statin use is associated with improved survival and cardiovascular outcomes in patients with atrial fibrillation and recent ischaemic stroke: A propensity-matched analysis of a global federated health database;European Stroke Journal;2024-09-10

2. Lipid management strategies for diabetic patients align with an evidence-based guideline;DARU Journal of Pharmaceutical Sciences;2024-09-06

3. Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials;Atherosclerosis;2024-09

4. Rationale for Increasing Doses of Statins in Everyday Clinical Practice;Kardiologiia;2024-08-31

5. GFR Decline Predicts Total Mortality and Mediates the Effect of Tryptophan Metabolism on Death Risk in Type 2 Diabetes;The Journal of Clinical Endocrinology & Metabolism;2024-08-13